A synthesis of literature has highlighted three major gaps: limited data on quantitative and spatial profiles of CD1a+ and CD208+ DCs in CRC from NAM through primary tumor to liver metastases; the absence of studies addressing landscape of DCs in synchronous versus metachronous CRC; few, often inconsistent, studies linking these subsets to patient outcomes. Here, CD1A is linked to colorectal carcinoma.